Hormone pills raise risk of kidney stones in postmenopausal women

10/11/2010 | Google

A study found that postmenopausal women who took either Premarin, an estrogen-only supplement, or Prempro, an estrogen plus progestin pill, were 21% more likely than those who took placebo to develop kidney stones. The study's lead author emphasized the importance of examining whether the benefits of the hormone in easing menopause symptoms such as hot flashes outweigh the risks for kidney stones and other complications.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD